Free Trial
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis

Health Sciences Acquisitions Co. 2 logo
$2.90 +0.01 (+0.35%)
As of 05/16/2025

About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ)

Key Stats

Today's Range
$2.79
$2.94
50-Day Range
$2.42
$4.51
52-Week Range
$9.41
$13.80
Volume
133,142 shs
Average Volume
205,918 shs
Market Capitalization
$32.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Receive HSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter.

HSAQ Stock News Headlines

Secure this "AI Fuel" Stock Before the Billionaires Buy It All
The Washington Post says America is running out of a key material needed for AI—and without it, companies like NVIDIA could be forced to shut down. While billionaires like Buffett and Gates scramble to secure access, one under-the-radar firm has quietly locked up supply. Bloomberg even calls it a “monopoly.” And it’s still trading near $20.
Quest Completes Acquisition Of Select Laboratory Assets From Allina Health
See More Headlines

HSAQ Stock Analysis - Frequently Asked Questions

Health Sciences Acquisitions Co. 2's stock was trading at $4.00 at the beginning of the year. Since then, HSAQ stock has decreased by 27.5% and is now trading at $2.90.
View the best growth stocks for 2025 here
.

Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering (IPO) on Tuesday, August 4th 2020. The company issued 13,900,000 shares at a price of $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Sciences Acquisitions Co. 2 investors own include Churchill Capital Corp IV (CCIV), FS Development (FSDC), Gores Holdings IV (GHIV), Gores Holdings V (GRSVU), Holicity (HOLUU), Kismet Acquisition One (KSMTU) and Lionheart Acquisition Co. II (LCAPU).

Company Calendar

Today
5/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:HSAQ
Web
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.62) per share
Price / Book
-4.68

Miscellaneous

Free Float
8,757,000
Market Cap
$32.51 million
Optionable
Not Optionable
Beta
0.09
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:HSAQ) was last updated on 5/18/2025 by MarketBeat.com Staff
From Our Partners